Marinus Pharmaceuticals, Inc. financial data

Symbol
MRNS on Nasdaq
Industry
Pharmaceutical Preparations
Location
5 Radnor Corporate Center Suite 500, 100 Matsonford Rd, Radnor, Pennsylvania
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
Q1 2024 - May 8, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 492 % -40.6%
Quick Ratio 9.75 %
Debt-to-equity 533 % +211%
Return On Equity -518 % -960%
Return On Assets -81.9 % -354%
Operating Margin -475 % +20.2%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 54.6M shares +10%
Common Stock, Shares, Outstanding 54.9M shares +10.6%
Entity Public Float 545M USD +204%
Common Stock, Value, Issued 55K USD +10%
Weighted Average Number of Shares Outstanding, Basic 56.9M shares +9.82%
Weighted Average Number of Shares Outstanding, Diluted 56.9M shares +9.82%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 28.3M USD +30.5%
Revenue from Contract with Customer, Excluding Assessed Tax 12.7M USD
Research and Development Expense 95.6M USD +6.37%
General and Administrative Expense 48.9M USD +76%
Costs and Expenses 163M USD +7.91%
Operating Income (Loss) -134M USD -4.11%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -143M USD -770%
Income Tax Expense (Benefit) -1.54M USD -145%
Net Income (Loss) Attributable to Parent -145M USD -313%
Earnings Per Share, Basic -2.64 USD/shares -300%
Earnings Per Share, Diluted -2.64 USD/shares -300%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 104M USD -29%
Cash, Cash Equivalents, and Short-term Investments 113M USD
Accounts Receivable, after Allowance for Credit Loss, Current 3.51M USD -70%
Inventory, Net 5.78M USD +15530%
Assets, Current 131M USD -40.3%
Property, Plant and Equipment, Net 3.74M USD -7.48%
Operating Lease, Right-of-Use Asset 1.5M USD +25%
Other Assets, Noncurrent 2.34M USD -16%
Assets 137M USD -39.4%
Accounts Payable, Current 6.13M USD +37.1%
Employee-related Liabilities, Current 2.83M USD -18.2%
Accrued Liabilities, Current 18.7M USD +19%
Liabilities, Current 42.8M USD +98.7%
Operating Lease, Liability, Noncurrent 582K USD -50.3%
Liabilities 154M USD +8.5%
Accumulated Other Comprehensive Income (Loss), Net of Tax -20K USD
Retained Earnings (Accumulated Deficit) -611M USD -31.2%
Stockholders' Equity Attributable to Parent -16.4M USD -119%
Liabilities and Equity 137M USD -39.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -37.5M USD +9.69%
Net Cash Provided by (Used in) Financing Activities 257K USD
Net Cash Provided by (Used in) Investing Activities 20.9M USD
Common Stock, Shares Authorized 150M shares 0%
Common Stock, Shares, Issued 54.9M shares +10.6%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -16.3M USD +82.6%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 104M USD -29%
Interest Paid, Excluding Capitalized Interest, Operating Activities 2.67M USD +23.9%
Deferred Tax Assets, Valuation Allowance 167M USD +35.4%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 168M USD +35.4%
Operating Lease, Liability 1.89M USD +3.23%
Depreciation 131K USD -16.6%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -145M USD -314%
Lessee, Operating Lease, Liability, to be Paid 2.03M USD -3.57%
Property, Plant and Equipment, Gross 5.74M USD +0.93%
Operating Lease, Liability, Current 1.31M USD +98.2%
Lessee, Operating Lease, Liability, to be Paid, Year Two 662K USD -21.2%
Lessee, Operating Lease, Liability, to be Paid, Year One 955K USD +13.7%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 140K USD -48.9%
Lessee, Operating Lease, Liability, to be Paid, Year Three 642K USD -23.6%
Deferred Tax Assets, Operating Loss Carryforwards 72.8M USD +25.4%
Current Income Tax Expense (Benefit) -1.54M USD -145%
Unrecognized Tax Benefits 0 USD
Additional Paid in Capital 594M USD +8.78%
Current State and Local Tax Expense (Benefit) -1.54M USD -163%
Share-based Payment Arrangement, Expense 17M USD +9.4%
Interest Expense 17.1M USD +30.2%